First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.

Vasavda, C; Ho, B K; Zhang, D Y; Williams, K A; Kaffenberger, B H; Kwatra, S G; Kwatra, M M

Vasavda, C; Ho, B K; Zhang, D Y; Williams, K A; Kaffenberger, B H; Kwatra, S G; Kwatra, M M.

Afiliación

Vasavda C; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Ho BK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Zhang DY; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Williams KA; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Kaffenberger BH; Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Kwatra MM; Department of Anesthesiology, Duke University School of Medicine, Durham, NC, 27701, USA.

Br J Dermatol ; 183(6): 1105-1107, 2020 12.

Article en En | MEDLINE | ID: mdl-32479649

Asunto(s)

Fosfoproteínas; Inhibidores de Proteínas Quinasas; Receptores ErbB; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfoproteínas / Inhibidores de Proteínas Quinasas Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google